Increasing colistin resistance is a global concern because colistin is used as a last resort for
the treatment of carbapenem-resistant Enterobacteriaceae infections. The plasmid-mediated …

The global dissemination of colistin resistance has received a great deal of attention.
Recently, the plasmid-mediated colistin resistance encoded by mcr genes in Escherichia …

The objective of this study was to determine the minimal inhibitory concentration of colistin
for Escherichia coli from food animals and the possible underlying colistin resistance …

Colistin is the last line of defense for the treatment of multidrug-resistant gram-negative
bacterial infections. However, colistin resistance is gradually increasing worldwide, with …

Objectives This study investigated the prevalence and characteristics of mcr-1-harbouring
Escherichia coli isolated from chickens in central China from 2014 to 2019. Methods A total …

The aim of this study was to assess the presence of mobile colistin resistance in bacteria
isolated from the swine production environment and to analyze the genomic environment of …

Colistin is indicated for the treatment of multidrug-resistant gram-negative bacterial
infections. However, the spread of colistin-resistant bacteria harbouring an mcr gene has …

Objective The widespread use of antibiotics in humans and animals has contributed to
growing rates of antibiotic resistance. Previously treatable bacterial infections now require …

Since its initial discovery in China in 2015, the plasmid-mediated colistin resistance gene
mcr-1 has been reported in Escherichia coli isolated from clinical samples, animals and …

Objectives Historically, colistin has been considered a last-line therapeutic option against
multidrug-resistant Gram-negative bacterial infections. However, chromosomally-encoded …